Anti-BMAL1 mAb-Discontinued (Monoclonal Antibody) (Discontinued)

|RbAp48 Polyclonal Antibody.

Specifications:

Description

We are sorry for the inconvenience; this product code has been discontinued.

This product has been discontinued.

|Polyclonal antibody of 100 μl targeting RbAp48 for ICC, IHC, WB.

Target: RbAp48
Product Type: Antibody
Size: -, 100 µl
Application: ICC
Conjugate: Unlabeled
Antibody Type: Polyclonal
Formulation: |50 µg IgG in 100 µl volume of PBS containing 50% glycerol, pH 7.2. Contains no preservatives.
Isotype: IgG
Immunogen: |Synthetic peptide (1-14 aa of human RbAp48) (MADKEAAFDDAVEEC)
Host Species: Rabbit
Species Reactivity: Hamster
Source: |This antibody was an Protein A column chromatography purified rabbit polyclonal antibody raised against synthesized peptide, MADKEAAFDDAVEEC, which corresponding to human RbAp48 (1-14 aa).
Reactivity: |This antibody reacts with human, mouse, rat and hamster RbAp48 (60 kDa) on Western blotting.
Gene ID Human:

406

|

5928

Gene ID Mouse:

11865

|

19646

Gene ID Rat:

29657

Storage Temperature: | -20°C
Regulatory Statement: |For Research Use Only. Not for use in diagnostic procedures.

Citations

|

  1. Honda H et al. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients. Atherosclerosis. 220, 493-501 (2012),
  2. Tarakida A et al. Hypercholesterolemia accelerates bone loss in postmenopausal women. Climacteric. 14, 105-11 (2011),
  3. Yamaoka-Tojo M et al. Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome. Nutr Metab (Lond). 8, 3 (2011)
Code D361-3
Product Type Antibody
Size '-, 100 µl
Application ICC
Price
Call for Price